References
Annane D, Sébille V, Duboc D, Le Heuzey JY, Sadoul N, Bouvier E, Belissant E (2008) Incidence and prognosis of sustained arrhythmias in critically ill patients. Am J Respir Crit Care Med 178:20–25
Klein Klouwenberg P, Frencken J, Kuipers S, Ong D, Peelen L, van Vught L, Schultz M, van der Poll T, Bonten M, Cremer O, On behalf of the MARS consortium (2017) Incidence, predictors, and outcomes of new-onset atrial fibrillation in critically ill patients with sepsis. Am J Respir Crit Care Med 195:205–211
Moss T, Forrest Calland J, Enfield K, Gomez-Manjarres D, Ruminski C, DiMarco J, Lake D, Moorman R (2017) New-onset atrial fibrillation in the critically ill. Crit Care Med 45:790–797
Walkey A, Hogarth K, Lip G (2015) Optimizing atrial fibrillation management. From ICU and beyond. Chest 148:859–864
Ghassemi M, Richter S, Eche I, Chen T, Danziger J, Celi L (2014) A data-driven approach to optimized medication dosing: a focus on heparin. Intensive Care Med 40:1332–1339
The Task Force for the management of atrial fibrillation of the European Society of cardiology (ESC) (2016) 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893–2962
Lau D, Nattel S, Kalman J, Sanders P (2017) Modifiable risk factors and atrial fibrillation. Circulation 136:583–596
Krijthe B, Heeringa J, Kors J, Hofman A, Franco O, Witteman J, Stricker B (2013) Serum potassium levels and risk of atrial fibrillation. The Rotterdam study. Int J Cardiol 168:5411–5415
Lu YY, Cheng CC, Chen YC, Lin YK, Chen SA, Chen YJ (2016) Electrolytes disturbances differentially regulate sinoatrial node and pulmonary vein activity: a contribution to hypokalemia-or hyponatremia-induced atrial fibrillation. Heart Rhythm 13:781–788
May Khan A, Lubitz S, Sullivan L, Sun J, Levy D, Vasan R, Magnani J, Ellinor P, Benjamin E, Wang T (2013) Low serum magnesium and the development of atrial fibrillation in the community. The Framingham heart study. Circulation 127:33–38
Rhodes A, Evans L, Alhazzani W, Levy M, Antonelli M, Ferrer F et al (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43:304–377
Gordon AC, Perkins GD, Singer M, McAuley DF, Orme RM, Santhakumaran S, Mason AJ, Cross M, Al-Beidh F, Best-Lane J, Brealey D, Nutt CL, McNamee JJ, Reschreiter H, Breen A, Liu KD, Ashby D (2016) Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med 375:1638–1648
Edwards JD, Wilkins RG (1987) Atrial fibrillation precipitated by acute hypovolemia. Br Med J 294:283–284
Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM (1997) Incidence of and risk factors for atrial fibrillation in older adults. Circulation 96:2455–2461
Schortgen F, Clabault K, Katsahian S, Devaquet J, Mercat A, Deye N, Dellamonica J, Bouadma L, Cook F, Beji O, Brun-Buisson C, Lemaire F, Brochard L (2012) Fever control using external cooling in septic shock. A randomized controlled trial. Am J Respir Crit Care Med 185:1088–1095
Gillinov A, Bagiella E, Moskowitz A, Raiten J, Groh M, Bowdish M et al (2016) Rate control versus rhythm control for atrial fibrillation after cardiac surgery. N Engl J Med 374:1911–1921
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Vieillard-Baron, A., Boyd, J. Non-antiarrhythmic interventions in new onset and paroxysmal sepsis-related atrial fibrillation. Intensive Care Med 44, 94–97 (2018). https://doi.org/10.1007/s00134-017-4986-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-017-4986-7